Nuzenio

Actio Bio

Actio Bio news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 12 latest news signals 11 publisher sources 100/100 entity strength

Latest news

Timeline

Mon, 10 Aug 2026 18:37:55 GMTJazz Acquires Actio Bioscience | PharmExec - Pharmaceutical Executive
Mon, 10 Aug 2026 16:17:36 GMTJazz Pharmaceuticals expands rare epilepsy pipeline with Actio Biosciences deal - European Pharmaceutical Review
Mon, 10 Aug 2026 15:16:17 GMTJazz expands epilepsy portfolio with buy of Actio Biosciences - The Pharma Letter
Mon, 10 Aug 2026 15:11:12 GMTJazz bets on epilepsy treatment with up to $1.32 billion deal for Actio - Reuters
Mon, 10 Aug 2026 14:55:28 GMTJazz commits up to $1.3B to buy Actio, bolster epilepsy pipeline - BioSpace
Mon, 10 Aug 2026 14:22:59 GMTJazz Pharmaceuticals to Acquire Actio Biosciences for $1.32 Billion - Pharmaceutical Executive

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Actio Bio.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

11 distinct publisher/source names are currently connected to this entity page.